1. Home
  2. TECH

TECH

Bio-Techne Corp

Health Care

Biotechnology: Biological Products (No Diagnostic Substances)

Nasdaq

as 04-15-2024 4:00pm EST

$
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.

Founded: 1976 Country:
United States
United States
Employees: N/A City: MINNEAPOLIS
Market Cap: 10.5B IPO Year: 1989
Target Price: $85.88 AVG Volume (30 days): 1.1M
Analyst Decision: Buy Number of Analysts: 9
Dividend Yield: 0.49% Dividend Payout Frequency: Quarterly
EPS: 1.37 EPS Growth: -14.91
52 Week Low/High: $51.79 - $89.91 Next Earning Date: 05-01-2024
Revenue: $1,144,999,000 Revenue Growth: 2.25%
Revenue Growth (this year): 2.93% Revenue Growth (next year): 8.72%

Share on Social Networks: